Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 9,567 shares at $56.86 ($545K) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($545k) by VP Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.92 | 2,891 | $162K | 29.7% |
| 2 | $56.86 | 3,309 | $188K | 34.5% |
| 3 | $58.02 | 3,367 | $195K | 35.8% |
| Total | $56.98 avg | 9,567 | $545K | 100% |
| Filing → |
| KITE | SELL | 2016-01-19 | $531K | — | Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |